Omada Health (OMDA) Director Jeryl L. Hilleman Receives 1,435 RSUs

What Happened
Jeryl L. Hilleman, a member of Omada Health's board of directors, was granted 1,435 restricted stock units (RSUs) on July 5, 2026 under the company's Non-Employee Director Compensation Program. The RSUs were recorded at a $0.00 acquisition price (i.e., awarded as compensation rather than bought) and each RSU represents the right to receive one share of common stock upon settlement. This filing is an amendment correcting a previously understated RSU grant and beneficial ownership amount.

Key Details

• Transaction date: July 5, 2026 — Grant/Award of RSUs (code A).
• Quantity: 1,435 RSUs; reported acquisition price: $0.00; recorded total consideration $0.
• Shares owned after transaction: the amended filing updates the reporting person's beneficial ownership; the exact total after the grant is corrected in the amendment (not specified in the excerpt).
• Footnotes: F1 — RSUs granted in lieu of retainer fees; settlement timing per the director compensation program. F2 — This Form 4/A corrects an administrative understatement in the original filing.
• Filing date: July 20, 2026 (amendment). The Form 4 was amended 15 days after the grant date to correct the reported numbers.

Context
RSU grants to non-employee directors are compensation, not open-market purchases or sales, and do not by themselves signal a buy/sell decision. Each RSU converts to one share when settled (timing per the program); there is no immediate sale reported. The amendment fixes reporting accuracy — timely and accurate Form 4s matter for regulatory transparency, though amendments to correct administrative errors are common.